Kieron L. Lim

Singapore, SG 
Singapore, SG 

Overview

Kieron Lim practices practicing medicine in Singapore, Singapore.

His clinical expertise encompasses Hepatitis, Hepatitis B, Liver Failure, Familial Hypertriglyceridemia, and Liver Transplant.

He is actively involved in clinical research, co-authoring 12 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Singapore, Singapore
Other Locations
Singapore

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Randomised Control Study for Inactive Chronic Hepatitis B Patients With Low Viral Load, With Peg-Interferon (INACTIVE)
Randomised Control Study for Inactive Chronic Hepatitis B Patients With Low Viral Load, With Peg-Interferon (INACTIVE)
Enrollment Status: Completed
Publish Date: July 14, 2025
Intervention Type: Drug
Study Drug: Peginterferon Alfa-2A
Study Phase: Phase 2/Phase 3
Hepatocellular Carcinoma Registry in Asia: The INSIGHT Registry
Hepatocellular Carcinoma Registry in Asia: The INSIGHT Registry
Enrollment Status: Completed
Publish Date: December 05, 2022
Open Label Study of Nucleus(t)Ide Treated Patients Randomised to Tenofovir, or Tenofovir + Telbivudine
Open Label Study of Nucleus(t)Ide Treated Patients Randomised to Tenofovir, or Tenofovir + Telbivudine
Enrollment Status: Unknown
Publish Date: March 18, 2019
Intervention Type: Drug
Study Drugs: Tenofovir Disoproxil, Telbivudine
Study Phase: Phase 4
View 2 Less Clinical Trials

12 Total Publications

Switching to or Add-on Peginterferon in Patients on Nucleos(t)ide Analogues for Chronic Hepatitis B: The SWAP RCT.
Switching to or Add-on Peginterferon in Patients on Nucleos(t)ide Analogues for Chronic Hepatitis B: The SWAP RCT.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: February 04, 2021

Frequently Asked Questions about Kieron L. Lim

Is Kieron L. Lim a top-rated expert for Hepatitis?

MediFind is an objective health platform that identifies experts based on real-world data. Kieron L. Lim is classified as an Experienced expert for Hepatitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Kieron L. Lim participate in research or clinical trials?

Yes. Kieron L. Lim has published 12 articles and abstracts on conditions like Hepatitis. You can view a list of Kieron L. Lim's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lim's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile